Grégoire Franoux

Grégoire Franoux is a highly accomplished professional with a diverse educational background and extensive experience in the life sciences and corporate finance sectors.

Grégoire holds a Global Executive MBA from INSEAD, a Master's degree from Institut d'Administration des Entreprises, a Master's degree from ESIEE PARIS, and has also studied at institutions like Danmarks Tekniske Universitet, Université Henri Poincaré, and IMD Business School, showcasing a commitment to continuous learning and professional development.

With a proven track record of leadership and strategic decision-making, Grégoire has held key roles in prestigious organizations such as Belfius, where he served as Head of Life Sciences Corporate Finance, and GFX BioCapital, where he was the Managing Director.

His professional journey includes significant roles such as Global Head of Business Development at Oxurion NV, Senior Director Corporate Licensing Business Development at Grünenthal, Director New Business Development at Flamel Technologies, and Licensing & Business Development Manager at Flamel Technologies, demonstrating a strong expertise in business development and licensing within the biotech industry.

Prior to these roles, Grégoire Franoux gained valuable experience as a Biotech Venture Capital Analyst at AXA Private Equity, a Transactions Service Consultant at MSM Group, and as a Junior Sales & Marketing Analyst at MP Biomedicals, highlighting his versatile skill set and adaptability across different domains.

Grégoire Franoux's career trajectory exemplifies a blend of academic excellence, industry knowledge, and hands-on experience, making him a respected figure in the fields of life sciences, corporate finance, and business development.